Opposing effects of the angiopoietins on the thrombin-induced permeability of human pulmonary microvascular endothelial cells

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  van der Heijden, Melanie ^a   van Nieuw Amerongen, Geerten P ^a   van Bezu, Jan ^a   Paul, Marinus A ^a   Groeneveld, A B Johan ^a   van Hinsbergh, Victor W M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBIN; TYROSINE; VASCULAR ENDOTHELIAL CADHERIN; ANGIOPOIETIN; CADHERIN; COAGULATING AGENT; LEUKOCYTE ANTIGEN; RECOMBINANT PROTEIN;

ARTICLE; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENZYME ACTIVITY; ENZYME INHIBITION; EXPOSURE; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; MACROMOLECULE; MICROVASCULAR ENDOTHELIAL CELL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PULMONARY MICROVASCULAR ENDOTHELIAL CELL; TRANSENDOTHELIAL ELECTRICAL RESISTANCE; CELL CULTURE; DRUG EFFECT; ENDOTHELIUM CELL; GENETICS; IMMUNOBLOTTING; IMPEDANCE; LUNG; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; TIME; VASCULARIZATION;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANGIOPOIETINS; ANTIGENS, CD; CADHERINS; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; COAGULANTS; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; HUMANS; IMMUNOBLOTTING; LUNG; PHOSPHORYLATION; RAC1 GTP-BINDING PROTEIN; RECEPTOR, TIE-2; RECOMBINANT PROTEINS; RHOA GTP-BINDING PROTEIN; THROMBIN; TIME FACTORS;

EID: 80051681175     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023448     Document Type: Article

References (58)

1. Maniatis NA, Orfanos SE, (2008) The endothelium in acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 14: 22-30.
2. Huang YQ, Sauthoff H, Herscovici P, Pipiya T, Cheng J, et al. (2008) Angiopoietin-1 increases survival and reduces the development of lung edema induced by endotoxin administration in a murine model of acute lung injury. Crit Care Med 36: 262-267.
3. Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC, et al. (2007) Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 4: 1525-1537.
4. McCarter SD, Mei SH, Lai PF, Zhang QW, Parker CH, et al. (2007) Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med 175: 1014-1026.
5. Mammoto T, Parikh SM, Mammoto A, Gallagher D, Chan B, et al. (2007) Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J Biol Chem 282: 23910-23918.
6. Kim SR, Lee KS, Park SJ, Min KH, Lee KY, et al. (2008) Angiopoietin-1 variant, COMP-Ang1 attenuates hydrogen peroxide-induced acute lung injury. Exp Mol Med 40: 320-331.
7. Witzenbichler B, Westermann D, Knueppel S, Schultheiss HP, Tschope C, (2005) Protective role of angiopoietin-1 in endotoxic shock. Circulation 111: 97-105.
8. Xu J, Qu J, Cao L, Sai Y, Chen C, et al. (2008) Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J Pathol 214: 472-481.
9. Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, et al. (2006) Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 12: 1286-1293.
10. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, et al. (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12: 235-239.
11. Van der Heijden M, Van Nieuw Amerongen GP, Koolwijk P, Van Hinsbergh VW, Groeneveld AB, (2008) Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax 63: 903-909.
12. Parikh SM, Mammoto T, Schultz A, Yuan HT, Christiani D, et al. (2006) Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 3: 356-370.
13. Van der Heijden M, Pickkers P, Van Nieuw Amerongen GP, Van Hinsbergh VW, Bouw MP, et al. (2009) Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality. Intensive Care Med 35: 1567-1574.
14. Finigan JH, (2009) The coagulation system and pulmonary endothelial function in acute lung injury. Microvasc Res 77: 35-38.
15. Kipnis E, Guery BP, Tournoys A, Leroy X, Robriquet L, et al. (2004) Massive alveolar thrombin activation in Pseudomonas aeruginosa-induced acute lung injury. Shock 21: 444-451.
16. Moy AB, Van Engelenhoven J, Bodmer J, Kamath J, Keese C, et al. (1996) Histamine and thrombin modulate endothelial focal adhesion through centripetal and centrifugal forces. J Clin Invest 97: 1020-1027.
17. Gorovoy M, Neamu R, Niu J, Vogel S, Predescu D, et al. (2007) RhoGDI-1 modulation of the activity of monomeric RhoGTPase RhoA regulates endothelial barrier function in mouse lungs. Circ Res 101: 50-58.
18. Rabiet MJ, Plantier JL, Rival Y, Genoux Y, Lampugnani MG, et al. (1996) Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb Vasc Biol 16: 488-496.
19. Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, et al. (2000) Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 87: 603-607.
20. Pizurki L, Zhou Z, Glynos K, Roussos C, Papapetropoulos A, (2003) Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production. Br J Pharmacol 139: 329-336.
21. Li X, Hahn CN, Parsons M, Drew J, Vadas MA, et al. (2004) Role of protein kinase Czeta in thrombin-induced endothelial permeability changes: inhibition by angiopoietin-1. Blood 104: 1716-1724.
22. Aird WC, (2007) Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 100: 174-190.
23. Beck GC, Yard BA, Breedijk AJ, Van Ackern K, Van der Woude FJ, (1999) Release of CXC-chemokines by human lung microvascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells. Clin Exp Immunol 118: 298-303.
24. Shelton JL, Wang L, Cepinskas G, Sandig M, Inculet R, et al. (2006) Albumin leak across human pulmonary microvascular vs. umbilical vein endothelial cells under septic conditions. Microvasc Res 71: 40-47.
25. Baumer Y, Spindler V, Werthmann RC, Bunemann M, Waschke J, (2009) Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown. J Cell Physiol 220: 716-726.
26. Van Nieuw Amerongen GP, Vermeer MA, Negre-Aminou P, Lankelma J, Emeis JJ, et al. (2000) Simvastatin improves disturbed endothelial barrier function. Circulation 102: 2803-2809.
27. Bogatcheva NV, Garcia JG, Verin AD, (2002) Molecular mechanisms of thrombin-induced endothelial cell permeability. Biochemistry (Mosc) 67: 75-84.
28. Langeler EG, Van Hinsbergh VWM, (1988) Characterization of an in vitro model to study the permeability of human arterial endothelial cell monolayers. Thromb Haemost 60: 240-246.
29. Madara JL, (1998) Regulation of the movement of solutes across tight junctions. Annu Rev Physiol 60: 143-159.
30. Dudek SM, Garcia JG, (2001) Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 91: 1487-1500.
31. Van der Heijden M, Versteilen AM, Sipkema P, Van Nieuw Amerongen GP, Musters RJ, et al. (2008) Rho-kinase-dependent F-actin rearrangement is involved in the inhibition of PI3-kinase/Akt during ischemia-reperfusion-induced endothelial cell apoptosis. Apoptosis 13: 404-412.
32. Yuan HT, Khankin EV, Karumanchi SA, Parikh SM, (2009) Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in endothelium. Mol Cell Biol 29: 2011-2022.
33. Leemreis JR, Versteilen AM, Sipkema P, Groeneveld AB, Musters RJ, (2006) Digital image analysis of cytoskeletal F-actin disintegration in renal microvascular endothelium following ischemia/reperfusion. Cytometry Part A 69A: 873-978.
34. Marcus BC, Gewertz BL, (1998) Measurement of endothelial permeability. Ann Vasc Surg 12: 384-390.
35. Dejana E, Orsenigo F, Lampugnani MG, (2008) The role of adherence junctions and VE-cadherin in the control of vascular permeability. J Cell Science 121: 2115-2122.
36. Gavard J, Patel V, Gutkind JS, (2008) Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 14: 25-36.
37. Wysolmerski RB, Lagunoff D, (1990) Involvement of myosin light-chain kinase in endothelial cell retraction. Proc Natl Acad Sci U S A 87: 16-20.
38. Kinney CM, Chandrasekharan UM, Mavrakis L, DiCorleto PE, (2008) VEGF and thrombin induce MKP-1 through distinct signaling pathways: role for MKP-1 in endothelial cell migration. Am J Physiol Cell Physiol 294: C241-C250.
39. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, (1999) Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4: 915-924.
40. Wang Y, Pampou S, Fujikawa K, Varticovski L, (2004) Opposing effect of angiopoietin-1 on VEGF-mediated disruption of endothelial cell-cell interactions requires activation of PKC beta. J Cell Physiol 198: 53-61.
41. Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, et al. (2008) Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 10: 527-537.
42. Baffert F, Le T, Thurston G, McDonald DM, (2006) Angiopoietin-1 decreases plasma leakage by reducing number and size of endothelial gaps in venules. Am J Physiol Heart Circ Physiol 290: H107-H118.
43. Kim KT, Choi HH, Steinmetz MO, Maco B, Kammerer RA, et al. (2005) Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2. J Biol Chem 280: 20126-20131.
44. Fukuhara S, Sako K, Minami T, Noda K, Kim HZ, et al. (2008) Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 10: 513-526.
45. Winderlich M, Keller L, Cagna G, Broermann A, Kamenyeva O, et al. (2009) VE-PTP controls blood vessel development by balancing Tie-2 activity. J Cell Biol 185: 657-671.
46. Hoang MV, Nagy JA, Senger DR, (2011) Active Rac1 improves pathological VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1. Blood 117: 1751-1760.
47. Cascone I, Audero E, Giraudo E, Napione L, Maniero F, et al. (2003) Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1. Blood 102: 2482-2490.
48. Fukuhara S, Mochizuki N, (2010) Signaling mechanism involved in regulation on endothelial cell-cell junctions. Yakugaku Zasshi 130: 1413-1420.
49. Jho D, Mehta D, Ahmmed G, Gao XP, Tiruppathi C, et al. (2005) Angiopoietin-1 opposes VEGF-induced increase in endothelial permeability by inhibiting TRPC1-dependent Ca2 influx. Circ Res 96: 1282-1290.
50. Oubaha M, Gratton JP, (2009) Phosphorylation of endothelial nitric oxide synthase by atypical PKC{zeta} contributes to angiopoietin-1-dependent inhibition of VEGF-induced endothelial permeability in vitro. Blood 114: 3343-3351.
51. Peters S, Cree IA, Alexander R, Turowski P, Ockrim Z, et al. (2007) Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability. Cytokine 40: 144-150.
52. Baumeister U, Funke R, Ebnet K, Vorschmitt H, Koch S, et al. (2005) Association of Csk to VE-cadherin and inhibition of cell proliferation. EMBO J 24: 1686-1695.
53. Seegar TC, Eller B, Tzvetkova-Robev D, Kolev MV, Henderson SC, et al. (2010) Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands. Mol Cell 37: 643-655.
54. Findley CM, Cudmore MJ, Ahmed A, Kontos CD, (2007) VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arterioscler Thromb Vasc Biol 27: 2619-2626.
55. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60.
56. Scharpfenecker M, Fiedler U, Reiss Y, Augustin HG, (2005) The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci 118: 771-780.
57. Schubert SY, Benarroch A, Monter-Solans J, Edelman ER, (2011) Primary monocytes regulate endothelial cell survival through secretion of angiopoietin-1 and activation of endothelial Tie2. Arterioscler Thromb Vasc Biol 31: 870-875.
58. Marron MB, Singh H, Tahir TA, Kavumkal J, Kim HZ, et al. (2007) Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2. J Biol Chem 282: 30509-30517.